Glucose regulated production of human insulin in rat hepatocytes

Gene Therapy

Volumn 7, Issue 3, 2000, Pages 205-214

  Thule P M ^a,c   Liu, J ^a   Phillips, L S ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Hepatocyte; Insulin; Liver

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE; HUMAN INSULIN; IMMUNOREACTIVE INSULIN; INSULIN; LUCIFERASE; PROINSULIN; PROTEINASE; PYRUVATE KINASE; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; GENE INSERTION; GENETIC TRANSFECTION; HEPATOMA CELL; IMMUNOPRECIPITATION; INSULIN RELEASE; LIVER CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSGENE;

EID: 0034004456     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301076     Document Type: Article

References (48)

1. Kay MA, Rothenberg S, Landen CN, Bellinger DA. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 1993; 262: 117-119.
2. Applebaum-Bowden D, Kobayashi J, Kashyap VS, Brown DR. Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium. J Clin Invest 1996; 97: 799-805.
3. Alino SF, Bobadilla M, Crespo J, Lejarreta M. Human α1-anti-trypsin gene transfer to in vivo mouse hepatocytes. Hum Gen Ther 1996; 7: 531-536.
4. Monahan PE, Samulski RJ, Tazelaar J, Xiao X. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in dog model of hemophila. Gene Therapy 1998; 5: 40-41.
5. Harding CO, Wild K, Chang D, Messing A. Metabolic engineering as therapy for inborn errors of metabolism - development of mice with phenylalanine hydroxylase expression in muscle. Gene Therapy 1998; 5: 677-683.
6. Rovers RR, Henry R, Schmeiser L, Kolterman O. The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 1984; 33: 762-770.
7. Simpson AM, Tuch BE, Swan MA, Tu J. Functional expression of the human insulin gene in a human hepatoma cell line (HEP G2). Gene Therapy 1995; 2: 223-231.
8. Simpson AM, Marshall GM, Tuch BE, Maxwell L. Gene therapy of diabetes: glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g). Gene Therapy 1997; 4: 1202-1215.
9. Groskreutz DJ, Sliwkowski MX, Gorman CM. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 1994; 269: 6241-6245.
10. Simonson GD, Groskreutz DJ, Gorman CM, MacDonald MJ. Synthesis and processing of genetically modified human proinsulin by rat mvoblast primary cultures. Hum Gen Ther 1996; 7: 71-78.
11. Lu D, Tamemoto H, Shibata H, Saito I. Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Therapy 1998; 5: 888-895.
12. Muzzin P, Eisensmith RC, Copeland KC, Woo SLC. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol 1997; 11: 833-837.
13. Luzi L, Hering BJ, Socci C, Raptis G. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 2611-2618.
14. Fioretto P, Steffes MW, Sutherland DER, Goetz FC. Reversal of lesions of diabetic nephropathy after pancreas transplantation. New Engl J Med 1998; 339: 69-75.
15. Sugiyama A, Hattori S, Tanaka S, Isoda F. Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Hormone Metabol Res 1997; 29: 599-603.
16. Kolodka TM, Finegold M, Moss L, Woo SLC. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci USA 1995; 92: 3293-3297.
17. Valera A, Fillat C, Costa C, Sabater J. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J 1994; 8: 440-447.
18. Kaneda Y, Iwai K, Uchida T. Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem 1989; 264: 12126-12129.
19. Selden R, Skoskiewicz MJ, Burke Howie KB, Russell PS. Implantation of genetically engineered fibroblasts into mice: implications for gene therapy. Science 1987; 236: 714-718.
20. Robertson DG, Marino EM, Thulé PM, Seneviratne CK. Insulin and glucocorticoids regulate IGFBP-1 expression via a common promoter region. Biochem Biophys Res Commun 1994; 200: 226-232.
21. Lefrancois-Martinez A-M, Diaz-Guerra M-J, Vallet V, Kahn A. Glucose-dependent regulation of the L-pyruvate kinase gene in a hepatoma cell line is independent of insulin and cyclic AMP. FASEB J 1994; 8: 89-96.
22. Unger R, Foster DW: Diabetes mellitus. In: Wilson JD et al (eds). William's Textbook of Endocrinology. WB Saunders Co: Philadelphia, 1998, pp 973-1059.
23. Taconic, Hematological Clinical Chemistry Values Sprague Dawley Rats. Tachonic Technical Library, 1-6. 1998, Internet Communication.
24. Smeekens SP, Chan SJ, Steiner DF. The biosynthesis and processing of neuroendocrine peptides: identification of proprotein convertases involved in intravesicular processing. Prog Brain Res 1992; 92: 235-246.
25. Steiner DF et al. The new enzymology of precursor processing endoproteases. J Biol Chem 1992; 267: 23435-23438.
26. Goswami R, Lacson R, Yang E, Sam R. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter. Endocrinol 1994; 134: 736-743.
27. Suh DS, Ooi GT, Rechler MM. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3′,5′-monophosphate, and phorbol esters, and inhibition by insulin. Mol Endocrinol 1994; 8: 794-805.
28. Goldstein S, Sertich G, Levan KR, Phillips LS. Nutrition and somatomedin. XIX. Molecular regulation of insulin-like growth factor-I in streptozotocin-diabetic rats. Mol Endocrinol 1988; 2: 1093-1100.
29. Pao C-I, Farmer PK, Begovic S, Goldstein S. Expression of hepatic insulin-like growth factor-I and insulin-like growth factor-binding protein-1 genes is transcriptionally regulated in streptozotocin-diabetic rats. Mol Endocrinol 1992; 6: 969-977.
30. Schnetzler B, Murakawa G, Abalos D, Halban P. Adaptation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence of the importance of posttranscriptional regulation. J Clin Invest 1993; 92: 272-280.
31. Vitullo JC, Aron DC, Miller RE. Control of insulin gene expression: implications for insulin gene therapy. J Lab Clin Med 1994; 124: 328-334.
32. Leibiger B, Moede T, Schwarz T, Brown GR. Short-term regulation of insulin gene transcription by glucose. Proc Natl Acad Sci USA 1998; 95: 9307-9312.
33. Gros L, Montoliu L, Riu E, Lebrigand L. Regulated production of mature insulin by non-β-cells. Hum Gen Ther 1997; 8: 2249-2259.
34. Regazzi R, Verchere CB, Halban PA, Polonsky KS. Insulin production: from gene to granule. Diabetol 1997; 40: B33-B38.
35. Tomita N, Higaki J, Oghihara T, Kondo T. A novel gene-transfer technique mediated by HVJ (Sendai virus), nuclear protein, and liposomes. Cancer Detect Prevent 1994; 18: 485-491.
36. Hartwig R, Danishefsky KJ. Studies on the assembly and secretion of fibrinogen. J Biol Chem 1991; 266: 6578-6585.
37. Dahn MS, Hsu CJ, Lange MP, Kimball SR. Factors affecting secretory protein production in primary cultures of rat hepatocytes (43570). Proc Soc Exp Biol Med 1993; 203: 38-44.
38. Dixon JL, Ginsberg HN. Hepatic synthesis of lipoproteins and apolipoproteins. Semin Liver Dis 1992; 12: 364-372.
39. Vaulont S, Puzenat N, Levrat F, Cognet M. Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors. J Mol Biol 1989; 209: 205-219.
40. Cognet M, Lone YC, Vaulont S, Kahn A. Structure of the rat L-type pyruvate kinase gene. J Mol Biol 1987; 196: 11-25.
41. Babajko S, Groyer A Interplay of the liver-enriched trans-acting factors, DBP and HNF1 in the transactivation of human IGFBP-1 promoter. Biochem Biophys Res Commun 1993; 196: 480-486.
42. Wanke IE, Wong NC. Specific problems facing gene therapy for insulin-dependent diabetes mellitus: glucose-regulated insulin secretion from hepatocytes. Proc Western Pharmacol Soc 1997; 40: 131-133.
43. Tuch BE, Tabiin MT, Casamento FM, Simpson AM. Transplantation of genetically engineered insulin-producing hepatocytes into immunoincompetent mice. Transplant Proc 1998; 30: 473.
44. Seglen PO. Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391-398.
45. Ginot F, Decaux J-F, Cognet M, Berbar T. Transfection of hepatic genes into adult rat hepatocytes in primary culture and their tissue-specific expression. Eur J Biochem 1989; 180: 289-294.
46. Bonifacino J. Analysis of proteins. Current Protocols in Molecular Biology, (10). New York: John Wiley & Sons, 1997.
47. Baker A, Saltik M, Lehrmann H, Killisch I. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Therapy 1997; 4: 773-782.
48. Marriott D, Gillece-Castro B, Gorman CM. Prohormone convertase-1 will process prorelaxin, a member of the insulin family of hormones. Mol Endocrinol 1992; 6: 1441-1450.